Cutaneous adverse reactions following SARS-CoV-2 vaccine booster dose: a real-life multicentre experience
- PMID: 35771093
- PMCID: PMC9349823
- DOI: 10.1111/jdv.18386
Cutaneous adverse reactions following SARS-CoV-2 vaccine booster dose: a real-life multicentre experience
Conflict of interest statement
The authors have no conflict of interest to declare.
Figures
Comment in
-
Skin reaction after SARS-CoV-2 vaccines Reply to 'cutaneous adverse reactions following SARS-CoV-2 vaccine booster dose: A real-life multicentre experience'.J Eur Acad Dermatol Venereol. 2023 Jan;37(1):e43-e44. doi: 10.1111/jdv.18531. Epub 2022 Aug 20. J Eur Acad Dermatol Venereol. 2023. PMID: 35972802 Free PMC article. No abstract available.
References
-
- Callaway E. COVID vaccine boosters: the most important questions. Nature 2021; 596: 178–180. - PubMed
-
- Stuart ASV, Shaw RH, Liu X et al. Immunogenicity, safety, and reactogenicity of heterologous COVID‐19 primary vaccination incorporating mRNA, viral‐vector, and protein‐adjuvant vaccines in the UK(com‐COV2): a single‐blind, randomised, phase 2, non‐inferiority trial. Lancet 2022; 399: 36–49. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
